C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2002
11/14/2002	US20020168363 Integrin/adhesion antagonists
11/14/2002	CA2452245A1 Recombinant fusion proteins and the trimers thereof
11/14/2002	CA2447407A1 Nucleic acids and proteins with thioredoxin reductase activity
11/14/2002	CA2447386A1 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2445049A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	CA2435142A1 Kinases and phosphatases
11/13/2002	EP1255853A2 Methods of protein destabilization and uses thereof
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255842A1 Larynx carcinoma-associated protein larcap-1
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/13/2002	EP1060261A4 Poly zinc finger proteins with improved linkers
11/13/2002	EP0584284B9 Recombinant dna-derived cholera toxin subunit analogs
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379782A Subunit optimized fusion proteins
11/12/2002	US6479626 Poly zinc finger proteins with improved linkers
11/12/2002	US6479459 Cytokine designated lerk-5
11/12/2002	CA2220684C Process for controlling sialylation of proteins produced by mammalian cell culture
11/12/2002	CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/12/2002	CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002	WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	WO2002088170A2 Cripto blocking antibodies and uses thereof
11/07/2002	WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002	WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002	WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002	WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002	WO2002016414A3 Composition for the elimination of autoreactive b-cells
11/07/2002	WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
11/07/2002	WO2001037881A9 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
11/07/2002	US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002	US20020165346 Isolated mammalian membrane protein genes; related reagents
11/07/2002	US20020165156 Tumor necrosis factor family and its blocking agent
11/07/2002	US20020165126 Method for inactivating gonadotrophs
11/07/2002	US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors
11/07/2002	US20020164738 Cell death inhibitory protein
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164690 Receptor based antagonists and methods of making and using
11/07/2002	US20020164617 Affinity selection-based screening of hydrophobic proteins
11/07/2002	CA2715570A1 Cripto blocking antibodies and uses thereof
11/07/2002	CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/06/2002	EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002	EP1254179A1 An in vivo screen using chemical inducers of dimerization
11/06/2002	EP0757720B1 Trimerising polypeptides, their manufacture and use
11/06/2002	CN1378593A Method and compostions for construction and use of fusion libraries
11/06/2002	CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6475756 Development of viruses resistant to inactivation by the human complement system
11/05/2002	CA2147124C Erythropoietin analogs
11/05/2002	CA2066777C Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection
10/2002
10/31/2002	WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002	WO2002086119A1 Transformed silkworm producing human collagen
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086079A2 T1r3 a novel taste receptor
10/31/2002	WO2002086058A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
10/31/2002	WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002	WO2002085936A1 Mutants of green fluorescent protein
10/31/2002	WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002	WO2002068585A3 Tip39 polypeptides
10/31/2002	WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002	WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002	WO2002060477A9 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same
10/31/2002	WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism
10/31/2002	WO2001098343A3 Conserved diaphanous-related formin autoregulatory domain (dad)
10/31/2002	WO2001053342A9 Chimeric prostate-homing peptides with pro-apoptotic activity
10/31/2002	WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002	US20020161202 For modulating apoptosis in mammalian cells
10/31/2002	US20020161201 For use in cancer diagnosis and therapy
10/31/2002	US20020161200 For therapy
10/31/2002	US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002	US20020160003 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
10/31/2002	US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering
10/31/2002	US20020159958 Methods for producing immunoglobulins containing protection proteins in plants and their use
10/31/2002	CA2483507A1 Enzyme and snp marker for disease
10/31/2002	CA2445197A1 T1r3 a novel taste receptor
10/31/2002	CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	CA2445011A1 Transformed silkworm producing human collagen
10/31/2002	CA2444691A1 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/30/2002	EP1252319A2 Combinatorial protein domains
10/30/2002	EP1252318A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid
10/30/2002	EP1252315A2 Method for the production of a protein
10/30/2002	EP1252311A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels
10/30/2002	EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
10/30/2002	EP1252192A2 Enhancing the circulating half-life of antibody-based fusion proteins
10/30/2002	EP1252187A2 Fil-1 theta dnas and polypeptides
10/30/2002	EP1251870A2 Novel use
10/30/2002	EP1140973A4 Protein-protein interactions in neurodegenerative disorders
10/30/2002	EP1071952A4 I kappa b and enhanced green fluorescent fusion protein
10/30/2002	CN1377370A C-peptide for the improved production of insulin and insulin analogues
10/29/2002	US6472511 Stimulation of an immune response with antibodies labeled with the α-galactosyl epitope

1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 295